Frazier Healthcare Partners
{{Short description|Healthcare private equity and venture capital firm}}
{{Infobox company
| name = Frazier Healthcare Partners
| logo = Frazier Healthcare Partners Logo.png
| type = Private
| genre =
| fate =
| predecessor =
| successor =
| foundation = 1991
| founder = Alan D. Frazier
| defunct =
| location_country = United States
| location = Two Union Square
| locations =
| area_served =
| key_people = Alan D. Frazier (Chairman)
| industry = Private equity
| products = {{ubl|Leveraged buyouts|Growth capital|Venture capital}}
| production =
| services =
| revenue =
| operating_income =
| net_income =
| aum = US$4.8 billion (2022)
| assets =
| equity =
| owner =
| num_employees =
| parent =
| divisions =
| subsid =
| homepage = {{URL|frazierhealthcare.com}}
| footnotes =
| intl =
}}
Frazier Healthcare Partners is a healthcare private equity and venture capital firm based in Seattle, Washington with offices in Menlo Park, California that invests across the U.S., Canada and Europe.{{cite web|title=Company Overview of Frazier Healthcare Partners|url=https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=20515|website=Bloomberg Business|accessdate=February 13, 2016}} The firm specializes in leveraged buyouts, growth equity and venture capital financing.{{Cite web|url=https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=20515|title=Frazier Healthcare Partners: Private Company Information - Bloomberg|website=www.bloomberg.com|access-date=2017-07-12}}
Background
Frazier Healthcare Partners was founded by Alan D. Frazier in 1991. With over $7.1 billion total capital raised, the firm has invested in over 200 companies and currently manages a portfolio of approximately 40 companies across healthcare services and life sciences sectors.{{cite web |title=AUM |url=https://aum13f.com/firm/frazier-management-llc |accessdate=May 19, 2022 |website=Frazier Management LLC}}
The firm’s Growth Buyout fund invests in healthcare and pharmaceutical services, medical products and related sectors. The Life Sciences fund invests in therapeutics and related areas that are addressing unmet medical needs through innovation.{{Cite news|url=https://www.frazierhealthcare.com/|title=Firm Overview, Growth Buyout and Life Sciences|date=2022}}
In 2021, the investment firm closed its 10th dedicated healthcare fund focused on middle market companies, which was oversubscribed and hit its hard cap of $1.4 billion in total capital commitments.{{Cite news|url=https://www.prnewswire.com/news-releases/frazier-healthcare-partners-closes-oversubscribed-1-4-billion-growth-buyout-fund-301300768.html|title=Frazier Healthcare Partners Closes Oversubscribed $1.4 Billion Growth Buyout Fund|date=2021|work=Reuters|access-date=2021-05-27}}
References
{{Reflist}}
External links
- {{URL|https://www.frazierhealthcare.com/|Official website}}
{{private equity firms}}
Category:Financial services companies established in 1991